Filing Details
- Accession Number:
- 0001104659-15-086780
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-24 13:02:23
- Reporting Period:
- 2015-12-23
- Filing Date:
- 2015-12-24
- Accepted Time:
- 2015-12-24 13:02:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1579428 | Axsome Therapeutics Inc. | AXSM | Pharmaceutical Preparations (2834) | 454241907 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1350416 | Randall Kaye | 25 Broadway, 9Th Floor New York NY 10004 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-12-23 | 1,000 | $9.03 | 6,022 | No | 4 | P | Indirect | By children |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By children |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.99 to $9.15, inclusive. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.